Alphabetical search
A| B| C| D| E| F| G| H| I| J| K| L| M| N| O| P| Q| R| S| T| U| V| W| X| Y| Z
Search by Name or Code Test
(Para exportar a PDF debe añadir la ténica a Mi Lista y lickar en Ver Mi lista, selección máxima 25 técnicas)
3
GLOBULE COUNT, BLOOD
Method:
Flow cytometry.
Mounting:
Delivery period:1
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Hematíes:
Females 65 74 Years 3.80 - 5.20 10Exp12/L
Hematocrito:
Both 9 11 Years 0.34 - 0.43 L/L * 100 = %
Plaquetas:
150.00 - 450.00 10Exp9/L
Hematocrito:
Males 14 17 Years 0.37 - 0.48 L/L * 100 = %
Hemoglobina:
Both 9 12 Years 12.00 - 15.00 g/L * 0.1 = g/dL
Índ.Distribución Hematíes:
Females 10.00 - 14.00 %
Plaquetocrito:
0.00 L/L * 100 = %
Hematíes:
Females 12 14 Years 3.80 - 5.00 10Exp12/L
Males 18 44 Years 4.70 - 6.00 10Exp12/L
Índ.Distribución Hematíes:
Males 11.00 - 15.00 %
Leucocitos:
Both 16 21 Years 4.50 - 11.00 10Exp9/L
Hematíes:
Both 6 8 Years 3.80 - 4.90 10Exp12/L
Hematocrito:
Males 17 45 Years 0.39 - 0.49 L/L * 100 = %
Volumen Corpuscular Medio:
83.00 - 97.00 fL
Hematíes:
Males 65 74 Years 3.80 - 5.80 10Exp12/L
Hematocrito:
Both 1 2 Years 0.32 - 0.40 L/L * 100 = %
Hemoglobina:
Males 18 44 Years 132.00 - 173.00 g/L * 0.1 = g/dL
Volumen Plaquetar Medio:
6.00 - 11.00 fL
Hematocrito:
Females 45 64 Years 0.35 - 0.47 L/L * 100 = %
Hemoglobina:
Females 15 17 Years 117.00 - 153.00 g/L * 0.1 = g/dL
I.Distribucion Plaquetas:
8.00 - 65.00 %
Leucocitos:
Both 4 5 Years 5.50 - 15.50 10Exp9/L
Both 5 6 Years 5.00 - 14.50 10Exp9/L
C.Hb.Corpuscular Media:
320.00 - 360.00 g/L * 0.1 = g/dL
Hb.Corpuscular Media:
27.00 - 31.00 pg
Hematíes:
Females 18 44 Years 4.20 - 5.40 10Exp12/L
Hematocrito:
Both 6 8 Years 0.33 - 0.41 L/L * 100 = %
Females 12 14 Years 0.34 - 0.44 L/L * 100 = %
Males 12 14 Years 0.35 - 0.45 L/L * 100 = %
Hemoglobina:
Both 3 4 Months 10.30 - 14.10 g/L * 0.1 = g/dL
Both 5 9 Years 11.50 - 14.50 g/L * 0.1 = g/dL
Females 12 14 Years 115.00 - 150.00 g/L * 0.1 = g/dL
Hematíes:
Both 0 12 Months 4.10 - 5.30 10Exp12/L
Males 15 17 Years 4.20 - 5.60 10Exp12/L
Hematocrito:
Both 0 1 Years 0.33 - 0.41 L/L * 100 = %
Hemoglobina:
Both 0 1 Months 10.70 - 17.10 g/L * 0.1 = g/dL
Both 1 2 Months 9.40 - 13.00 g/L * 0.1 = g/dL
Both 1 5 Years 11.00 - 14.00 g/L * 0.1 = g/dL
Males 45 64 Years 131.00 - 172.00 g/L * 0.1 = g/dL
Leucocitos:
Both 9 16 Years 4.50 - 13.50 10Exp9/L
Hematíes:
Both 9 11 Years 3.90 - 5.10 10Exp12/L
Females 15 17 Years 3.90 - 5.10 10Exp12/L
Males 45 64 Years 4.20 - 5.60 10Exp12/L
Hematocrito:
Both 3 5 Years 0.32 - 0.42 L/L * 100 = %
Females 14 17 Years 0.34 - 0.44 L/L * 100 = %
Hemoglobina:
Females 65 74 Years 117.00 - 161.00 g/L * 0.1 = g/dL
Leucocitos:
Both 7 8 Years 4.50 - 13.50 10Exp9/L
Hematíes:
Both 3 5 Years 3.70 - 4.90 10Exp12/L
Females 45 64 Years 3.80 - 5.30 10Exp12/L
Hemoglobina:
Males 65 74 Years 126.00 - 174.00 g/L * 0.1 = g/dL
Leucocitos:
Both 1 2 Years 6.00 - 17.00 10Exp9/L
Hematíes:
Both 1 2 Years 3.80 - 4.80 10Exp12/L
Hematocrito:
Females 17 45 Years 0.35 - 0.45 L/L * 100 = %
Females 64 74 Years 0.35 - 0.47 L/L * 100 = %
Hemoglobina:
Females 18 44 Years 117.00 - 155.00 g/L * 0.1 = g/dL
Females 45 64 Years 117.00 - 160.00 g/L * 0.1 = g/dL
Males 12 14 Years 120.00 - 160.00 g/L * 0.1 = g/dL
Males 15 17 Years 117.00 - 166.00 g/L * 0.1 = g/dL
Leucocitos:
Both 0 6 Months 6.00 - 17.50 10Exp9/L
Hematíes:
Males 12 14 Years 4.10 - 5.20 10Exp12/L
Hematocrito:
Males 45 64 Years 0.39 - 0.50 L/L * 100 = %
Males 64 74 Years 0.37 - 0.51 L/L * 100 = %
Review:
17/05/2013
114
GAP (GRANULOCYTIC ALKALINE PHOSPHATASE), BLOOD
Method:
Microscopic observation.
Mounting:
Delivery period:7
Sample:
3 mL Total blood Sodium Citrate (2-8 ºC - Refrigerate)
Alt. 3 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 Sample/s Hematological extension (2-8 ºC - Refrigerate)
Sample extraction:
Do not use EDTA as an anticoagulant.
Transport:
Use a slide carrier box.
Reference V.:
20.00 - 40.00 Indice
Review:
21/11/2010
155
GLYCOSYLATED HEMOGLOBIN, BLOOD
Method:
Capillary electrophoresis.
Mounting:
Delivery period:1
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Hemoglobina A1:
5.00 - 8.50 %
Hemoglobina A1c:
4.30 - 6.10 %
Review:
05/03/2004
384
GLUCOSE, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Fluoride EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:

Adults 3.89 - 5.83 mmol/L * 18 = mg/dL
Children 3.33 - 5.55 mmol/L * 18 = mg/dL
Review:
09/04/2013
385
GLUCOSE, SERUM Baseline
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Baseline serum (2-8 ºC - Refrigerate)
Reference V.:
Females < 5.80 mmol/L * 18 = mg/dL
Both 0 9 Months 1.10 - 3.30 mmol/L * 18 = mg/dL
Both 1 15 Years 3.30 - 5.60 mmol/L * 18 = mg/dL
Both 15 60 Years 3.60 - 5.90 mmol/L * 18 = mg/dL
Both 60 90 Years 4.60 - 6.40 mmol/L * 18 = mg/dL
Both 9 12 Months 2.80 - 4.40 mmol/L * 18 = mg/dL
386
GLUCOSE, SERUM 30 m
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum 30m (2-8 ºC - Refrigerate)
Reference V.:
Not available
387
GLUCOSE, SERUM 60 m
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum 60m (2-8 ºC - Refrigerate)
Reference V.:
Females < 10.60 mmol/L * 18 = mg/dL
Females < 7.80 mmol/L * 18 = mg/dL
388
GLUCOSE, SERUM 90 m
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum 90m (2-8 ºC - Refrigerate)
Reference V.:
Not available
389
GLUCOSE, SERUM 120 m
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum 120m (2-8 ºC - Refrigerate)
Reference V.:
Females < 9.20 mmol/L * 18 = mg/dL
390
GLUCOSE, SERUM 150 m
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum 150m (2-8 ºC - Refrigerate)
Reference V.:
Not available
Review:
29/09/2014
391
GLUCOSE, SERUM 180 m
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum 180m (2-8 ºC - Refrigerate)
Reference V.:
< 8.10 mmol/L * 18 = mg/dL
392
GLUCOSE, SERUM 240 m
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum 240 m. (2-8 ºC - Refrigerate)
Reference V.:
Not available
399
GLUCOSE, SERUM POSTPANDRIAL
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Fluoride EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
Not established.
Review:
29/10/2014
403
GLUCOSE, SERUM 300 m
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum 300 m. (2-8 ºC - Refrigerate)
494
GLUCOSE 6 PHOSPHATE DEHYDROGENASE (G-6-DPH), ERYTHROCYTES
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Total blood Sodium Citrate (2-8 ºC - Refrigerate)
Reference V.:
Hematocrito:
Females 14 17 Years 0.34 - 0.44 L/L * 100 = %
Hemoglobina:
Males 12 14 Years 120.00 - 160.00 g/L * 0.1 = g/dL
Females 15 17 Years 117.00 - 153.00 g/L * 0.1 = g/dL
Hematocrito:
Males 14 17 Years 0.37 - 0.48 L/L * 100 = %
221.00 - 570.00 U/10Exp12 eritr * 1 = mU/10Exp9 eritr
Hematocrito:
Females 17 45 Years 0.35 - 0.45 L/L * 100 = %
Hemoglobina:
Both 3 4 Months 10.30 - 14.10 g/L * 0.1 = g/dL
Females 45 64 Years 117.00 - 160.00 g/L * 0.1 = g/dL
Females 65 74 Years 117.00 - 161.00 g/L * 0.1 = g/dL
Males 45 64 Years 131.00 - 172.00 g/L * 0.1 = g/dL
Hematocrito:
Both 0 1 Years 0.33 - 0.41 L/L * 100 = %
Females 45 64 Years 0.35 - 0.47 L/L * 100 = %
Hemoglobina:
Both 0 1 Months 10.70 - 17.10 g/L * 0.1 = g/dL
Both 9 12 Years 12.00 - 15.00 g/L * 0.1 = g/dL
Hematocrito:
Females 64 74 Years 0.35 - 0.47 L/L * 100 = %
Hemoglobina:
Both 5 9 Years 11.50 - 14.50 g/L * 0.1 = g/dL
Males 65 74 Years 126.00 - 174.00 g/L * 0.1 = g/dL
Hematocrito:
Males 45 64 Years 0.39 - 0.50 L/L * 100 = %
Hemoglobina:
Both 1 2 Months 9.40 - 13.00 g/L * 0.1 = g/dL
7.00 - 20.50 U/g Hb * 0.0645 = MU/mol Hb
Hematocrito:
Both 3 5 Years 0.32 - 0.42 L/L * 100 = %
Both 9 11 Years 0.34 - 0.43 L/L * 100 = %
Males 12 14 Years 0.35 - 0.45 L/L * 100 = %
Females 12 14 Years 0.34 - 0.44 L/L * 100 = %
Males 64 74 Years 0.37 - 0.51 L/L * 100 = %
Hemoglobina:
Females 18 44 Years 117.00 - 155.00 g/L * 0.1 = g/dL
Males 15 17 Years 117.00 - 166.00 g/L * 0.1 = g/dL
Males 18 44 Years 132.00 - 173.00 g/L * 0.1 = g/dL
Hematocrito:
Both 6 8 Years 0.33 - 0.41 L/L * 100 = %
Males 17 45 Years 0.39 - 0.49 L/L * 100 = %
Hemoglobina:
Both 1 5 Years 11.00 - 14.00 g/L * 0.1 = g/dL
Hematocrito:
Both 1 2 Years 0.32 - 0.40 L/L * 100 = %
Hemoglobina:
Females 12 14 Years 115.00 - 150.00 g/L * 0.1 = g/dL
Review:
22/05/2013
500
GAMMA GLUTAMYL TRANSFERASE (GGT), SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Reference V.:
Males < 1.22 uKat/L * 59.988 = U/L
Females < 0.63 uKat/L * 59.988 = U/L
Review:
09/04/2013
527
GLUTAMATE DEHYDROGENASE, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Females < 50.00 nKat/L * 17.0 = U/L
Males < 68.00 nKat/L * 17.0 = U/L
608
GLUCIDE DEFICIENT TRANSFERRIN (DISIALOTRANSFERRIN), SERUM
Method:
Immunonephelometry.
Mounting:
Delivery period:7
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Discriminant V.:
< 2.50 %
Review:
25/09/2012
1037
GLYCOPROTEIN HORMONE FREE ALPHA SUBUNIT, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
0.5 mL Serum (-8 ºC - Freeze)
Alt. 0.5 mL Plasma Sodium heparin (-8 ºC - Freeze)
Reference V.:
Males < 0.70 mUI/mL
Postmenopause Females < 1.30 mUI/mL
Premenopause Females < 0.60 mUI/mL
Review:
03/07/2011
1044
GASTRIN, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Serum (-8 ºC - Freeze)
Sample extraction:
Separate serum as soon as possible.
Patient preparation:
The patient should not drink coffee or tea while fasting.
The patient should not take antacids for 24 hours prior to the analysis.
The patient should not smoke during the 24 hours before the test.
Reference V.:
Both 1 16 Years 4.80 - 60.00 pmol/L * 2.08333 = ng/L
Both 0 4 Days 57.60 - 87.80 pmol/L * 2.08333 = ng/L
Both > 16 Years < 51.84 pmol/L * 2.08333 = ng/L
Review:
20/07/2009
1045
GLUCAGON, PLASMA
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:7
Sample:
500 uL Plasma Tripotassium EDTA Trasylol (-8 ºC - Freeze)
Reference V.:
< 60.00 pmol/L * 0.291 = pg/mL
1046
GH (SOMATOTROPIN), SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
500 uL Serum (2-8 ºC - Refrigerate)
Reference V.:
Females < 360.00 pmol/L * 45.2 = ug/L
Males < 136.00 pmol/L * 45.2 = ug/L
1048
GH (SOMATOTROPIN), SERUM Baseline
Method:
Chemicalimmuno luminiscense.
Mounting:
Delivery period:1
Sample:
0.5 mL Baseline serum (2-8 ºC - Refrigerate)
Reference V.:
Females < 360.00 pmol/L / 45.2 = ug/L
Males < 136.00 pmol/L / 45.2 = ug/L
1049
GH (SOMATOTROPIN), SERUM 15 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
0.5 mL Serum 15 m. (2-8 ºC - Refrigerate)
1050
GH (SOMATOTROPIN), SERUM 30 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
0.5 mL Serum 30m (2-8 ºC - Refrigerate)
1051
GH (SOMATOTROPIN), SERUM 60 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
0.5 mL Serum 60m (2-8 ºC - Refrigerate)
1052
GH (SOMATOTROPIN), SERUM 90 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
0.5 mL Serum 90m (2-8 ºC - Refrigerate)
1053
GH (SOMATOTROPIN), SERUM 120 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
0.5 mL Serum 120m (2-8 ºC - Refrigerate)
1054
GH (SOMATOTROPIN), SERUM 180 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
0.5 mL Serum 180m (2-8 ºC - Refrigerate)
1055
GH (SOMATOTROPIN), SERUM post-exercise
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
0.5 mL Post-exercise serum (2-8 ºC - Refrigerate)
Reference V.:

1057
GH (SOMATOTROPIN), SERUM 150 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
0.5 mL Serum 150m (2-8 ºC - Refrigerate)
1248
GENTAMICIN, SERUM
Method:
Polarized Immunofluorescense.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Therapeutic R.:

Peak 10.40 - 20.90 umol/L * 0.478469 = ug/mL
Toxic C.:

Trough >= to 8.36 umol/L * 0.478469 = ug/mL
Therapeutic R.:

< 8.36 umol/L * 0.478469 = ug/mL
Toxic C.:

Peak >= to 20.90 umol/L * 0.478469 = ug/mL
Review:
09/04/2013
1308
GUANIDINOACETATE AND CREATINE, PLASMA
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:32
Sample:
3 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Reference V.:
Both > 12 Years 1.20 - 3.60 umol/L
Both 0 11 Years 15.00 - 118.00 umol/L
Both 0 11 Years 0.70 - 2.70 umol/L
Both > 12 Years 18.00 - 112.00 umol/L
1347
GLOMERULAR FILTRATE (CKD-EPI), SERUM
Method:
Molecular absorption spectrometry + calculation
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Discriminant V.:
Filtrado Glomerular:
> 60 mL/min/1,73 m2
1427
GASTRIC PARIETAL CELL ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/40 Titulo
Negative:
< 1/40 Titulo
Review:
26/06/2013
1465
GIARDIA INTESTINALIS ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/16 Titulo
Negative:
< 1/16 Titulo
Review:
21/01/2009
1468
GIARDIA INTESTINALIS ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Please mark specimens clearly as "acute" or "convalescent."
Interpretation:
Positive: >= to 1/32 Titulo
Negative:
< 1/32 Titulo
R.Values:
The study of two serum specimens obtained at an interval of 14-21 days is recommended to confirm recent infection.
Review:
02/12/2008
1707
GAD/65 K ANTIBODIES, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 0.90 U/mL
Review:
30/05/2007
1745
GLUTARIC ACIDURIA TYPE I, URINE
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:18
Sample:
20 mL Urine (-8 ºC - Freeze)
Request form:
Clinical information required.
It´s necessary the birth date.
Reference V.:
2.00 - 14.00 mmol/mol creat.
2.00 - 10.00 mmol/mol creat.
1756
GLYCEROL KINASE DEFICIT STUDY, URINE
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:22
Sample:
10 mL Urine (-8 ºC - Freeze)
Request form:
Clinical information required.
Reference V.:
1.00 - 83.00 mmol/mol creat.
1769
GM-1 (MONOSIALOGANGLIOSIDE) ANTIBODIES, IgG, CSF
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
1770
GM-1 (MONOSIALOGANGLIOSIDE) ANTIBODIES, IgM, CSF
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
1771
GM-1 (MONOSIALOGANGLIOSIDE) IgM ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
1773
GM-1 (MONOSIALOGANGLIOSIDE) ANTIBODIES, IgG, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
1835
GLUCOSE, URINE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
0.10 - 0.80 mmol/L * 18.0 = g/L
1898
GALACTOSE, URINE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:11
Sample:
1 mL Urine (2-8 ºC - Refrigerate)
Reference V.:

Infants (exclusively dairy diet) < 0.83 mmol/L * 181.818 = mg/L
Non infants < 0.08 mmol/L * 181.818 = mg/L
2118
GLUCOSE, SYNOVIAL FLUID
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Biologic fluid (2-8 ºC - Refrigerate)
Reference V.:
Not available
2119
GLUCOSE, PLEURAL FLUID
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Biologic fluid (2-8 ºC - Refrigerate)
Reference V.:
Not available
2120
GLUCOSE, CSF
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Both > 12 Years 2.20 - 3.90 mmol/L * 18.0 = mg/dL
Both 0 12 Years 3.30 - 4.40 mmol/L * 18.0 = mg/dL
2195
GLYCOLIC ACID (GLYCOLATE), URINE
Method:
Gas Chromatography.
Mounting:
Delivery period:36
Sample:
1 mL Urine (2-8 ºC - Refrigerate)
Sample extraction:
Before workday.
Second voided urine specimen.
Reference V.:
< 50.00 mg/g crea.
Review:
05/03/2004
2212
GM-2 (MONOSIALOGANGLIOSIDE) ANTIBODIES, IgG, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
2213
GM-2 (MONOSIALOGANGLIOSIDE) ANTIBODIES, IgM, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
2215
GM-3 (MONOSIALOGANGLIOSIDE) ANTIBODIES, IgG, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
2216
GM-3 (MONOSIALOGANGLIOSIDE) ANTIBODIES, IgM, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
2217
GD-1a (DISIALOGANGLIOSIDE) ANTIBODIES, IgG, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
2218
GD-1a (DISIALOGANGLIOSIDE) ANTIBODIES, IgM, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
2219
GD-1b (DISIALOGANGLIOSIDE) ANTIBODIES, IgG, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
2220
GD-1b (DISIALOGANGLIOSIDE) IgM ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
2221
GT-1b (TRISIALOGANGLIOSIDES) ANTIBODIES, IgG, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
2222
GT-1b (TRISIALOGANGLIOSIDES) ANTIBODIES, IgM, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
2223
GQ-1b (TETRASIALOGANGLIOSIDES) ANTIBODIES, IgM, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
2224
GQ-1b (TETRASIALOGANGLIOSIDES) ANTIBODIES, IgG, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
2228
GAMMA-HEXACHLOROCYCLOHEXANE, BLOOD
Method:
Gas Chromatography -electron capture.
Mounting:
Delivery period:17
Sample:
4 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Use vacuum tube (Vacutainer type).
Reference V.:

Exposed personnel (Lindane) < 25.00 ug/L
Unexposed personnel < 10.00 ug/L
Review:
17/01/2011
2690
GAMMA-AMINOBUTYRIC ACID, URINE
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:17
Sample:
1 mL Urine (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Review:
22/03/2004
5019
GINECOLOGICAL LIQUID BASED CYTOLOGY (BETESDA)
Method:
Papanicolaou smear / Microscopic observation.
Mounting:
Delivery period:5
Sample:
Alt. 1 Smear Double endocervical-exocervical specimen PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Endocervical exudate PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Bartholins gland exudate PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Vaginal exudate PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Endocervical specimen PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Endometrial specimen PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Single vaginal specimen PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Vulvar specimen PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Cervicovaginal specimen PreservCyt ® (12-20 ºC - Ambient Temp.)
Sample extraction:
Use PreservCyt medium.
R.Values:
Reported for each case.
Review:
05/02/2009
5020
GINECOLOGICAL LIQUID BASED CYTOLOGY
Method:
Papanicolaou smear / Microscopic observation.
Mounting:
Delivery period:5
Sample:
Alt. 1 Smear Double endocervical-exocervical specimen PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Endocervical exudate PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Bartholins gland exudate PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Vaginal exudate PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Endocervical specimen PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Endometrial specimen PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Single vaginal specimen PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Vulvar specimen PreservCyt ® (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Cervicovaginal specimen PreservCyt ® (12-20 ºC - Ambient Temp.)
Sample extraction:
Use PreservCyt medium.
R.Values:
Reported for each case.
Review:
12/12/2008
5029
GENITAL CYTOLOGY (BETESDA)
Method:
Papanicolaou smear / Microscopic observation.
Mounting:
Delivery period:5
Sample:
1 Smear Cervicovaginal specimen (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Double endocervical-exocervical specimen (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Endocervical exudate (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Bartholins gland exudate (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Vaginal exudate (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Endocervical specimen (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Endometrial specimen (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Single vaginal specimen (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Vulvar specimen (12-20 ºC - Ambient Temp.)
Sample extraction:
Fixation with Cytospray.
R.Values:
Reported for each case.
Review:
05/02/2009
5031
GENITAL CYTOLOGY
Method:
Papanicolaou smear / Microscopic observation.
Mounting:
Delivery period:8
Sample:
1 Smear Cervicovaginal specimen (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Double endocervical-exocervical specimen (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Endocervical exudate (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Bartholins gland exudate (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Vaginal exudate (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Endocervical specimen (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Endometrial specimen (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Single vaginal specimen (12-20 ºC - Ambient Temp.)
Alt. 1 Smear Vulvar specimen (12-20 ºC - Ambient Temp.)
Sample extraction:
Fixation with Cytospray.
R.Values:
Reported for each case.
Review:
12/12/2008
7045
GRAHAM STRIP
Method:
Microscopic observation.
Mounting:
Delivery period:3
Sample:
3 Sample/s Transparent adhesive tape (2-8 ºC - Refrigerate)
Sample extraction:
See general instructions.
Reference V.:
Reported for each case
7069
GRAMM STAIN
Method:
Microscopic observation.
Mounting:
Delivery period:2
Sample:
5 mL SS (2-8 ºC - Refrigerate)
5 mL BAS (2-8 ºC - Refrigerate)
1 piece/s Biopsy (2-8 ºC - Refrigerate)
5 mL Sputum/phlegm (2-8 ºC - Refrigerate)
1 Smear Exudate (2-8 ºC - Refrigerate)
1 Smear Smear (2-8 ºC - Refrigerate)
5 mL Faeces (2-8 ºC - Refrigerate)
5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
5 mL Biologic fluid (2-8 ºC - Refrigerate)
5 mL Urine (2-8 ºC - Refrigerate)
5 mL Secretion (2-8 ºC - Refrigerate)
5 mL Semen (2-8 ºC - Refrigerate)
5 mL Suppuration (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Extraction date is required.
The type of specimen sent is required.
Reference V.:
TINCIÓN DE GRAM:
Reported for each case
Review:
19/04/2010
8020
GENE TP53 SUPRESOR TUMORAL (SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
26/03/2004
8076
GALACTOMANNAN ASPERGILLUS ANTIGEN, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:6
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
12/01/2009
8091
GLUTATHIONE PEROXIDASE, BLOOD
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:25
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
54.78 - 59.58 U/g prot.
Review:
18/03/2005
8093
GLUTATHIONE REDUCTASE, BLOOD
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:35
Sample:
1 mL Serum (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Reference V.:
42.00 - 80.00 U/L
Review:
18/03/2005
8260
GILBERT SYNDROME (GENE UGT1A1), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:20
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
22/10/2013
8274
GLOMERULAR FILTRATE, SERUM
Method:
Molecular absorption spectrometry + calculation
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Filtrado Glomerular:
Not available
8354
GANGLIOSIDE ANTIBODIES, IgG, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
GD1b (G. DISIALO) IgG:
Negative
GM2 (G. MONOSIALO) IgG:
Negative
GQ1b (G. TETRASIALO) IgG:
Negative
GD1a (G. DISIALO) IgG:
Negative
GM3 (G. MONOSIALO) IgG:
Negative
GT1b (G. TRISIALO) IgG:
Negative
GM1 (G. MONOSIALO) IgG:
Negative
8355
GANGLIOSIDE ANTIBODIES, IgM, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Review:
18/04/2015
8356
GANGLIOSIDE ANTIBODIES IgG, CSF
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
GQ1b (G. TETRASIALO) IgG:
Negative
Negative
Negative
Negative
Negative
GM1 (G. MONOSIALO) IgG:
Negative
Review:
30/10/2012
8357
GANGLIOSIDE ANTIBODIES, IgM, CSF
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
Negative
Negative
Negative
Negative
GM1 (G. MONOSIALO) IgM:
Negative
Negative
Review:
30/10/2012
8394
GANGLIOSIDES + SULFATIDES IgG ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:17
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
8395
GANGLIOSIDES + SULFATIDES IgM ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:17
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Review:
06/05/2014
8516
GENETIC PROFILE OF ADOPTION
Method:
Polymerase chain reaction.
Mounting:
Delivery period:10
Sample:
1 Sample/s Bucal smear (2-8 ºC - Refrigerate)
Sample extraction:
Request the sample taking protocol to the laboratory.
Reference V.:
Reported for each case
8524
GENETIC STUDY OF THE OBESITY
Method:
Polymerase chain reaction.
Mounting:
Delivery period:20
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
R.Values:
Reported for each case.
Review:
27/02/2014
8556
GLUTARIC ACIDURIA TYPE I (GCDH GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
8566
GORLIN GOLTZ SYNDROME (PTCH1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
23/07/2008
8705
GUANIDINOACETATE AND CREATINE, URINE
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:32
Sample:
15 mL Urine (-8 ºC - Freeze)
Reference V.:
Guanidino acetato:
Both 7 12 Years 9.00 - 97.00 mmol/mol creat.
Both 0 6 Years 13.00 - 139.00 mmol/mol creat.
Both > 12 Years 11.00 - 84.00 mmol/mol creat.
Creatina/Creatinina:
Both 0 6 Years 0.02 - 1.63 mmol/mmol creat
Both 7 12 Years 0.02 - 1.10 mmol/mmol creat
Both > 12 Years 0.02 - 0.40 mmol/mmol creat
Review:
17/02/2011
8918
GRANULOCYTE-AGGLUTINATION, SERUM
Method:
Agglutination.
Mounting:
Delivery period:7
Sample:
5 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
8935
GRANULOCYTE GENOTYPE, BLOOD
Method:
PCR-SSP.
Mounting:
Delivery period:7
Sample:
10 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Samples must come to our laboratory from Monday to Thursday. Wednesday is the last possible day for blood collection.
Reference V.:
Reported for each case
Review:
23/02/2010
8936
GRANULOCYTOPENIA AUTOIMMUNE STUDY, SERUM AND BLOOD
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:17
Sample:
5 mL Total blood Sodium Citrate (2-8 ºC - Refrigerate)
55 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
5 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Samples must come to our laboratory from Monday to Thursday. Wednesday is the last possible day for blood collection.
Transport:
It is necessary to warn the laboratory of the sending of these samples and indicate the analysis that is requested.
Sample extraction:
Specimen must be received within 24 h after extraction. Avoid collecting on the day before weekends or holidays.
Reference V.:
Reported for each case
8980
GHRH (RELEASING FACTOR GROWTH HORMONE), PLASMA
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:31
Sample:
1 mL Plasma Tripotassium EDTA Trasylol (-8 ºC - Freeze)
Sample extraction:
Pick up 5 mL of blood in a vacutainer EDTA K3 hot tube with 250 KIU of Trasylol (Aprotinine).
Cool the tube with blood in an ice bath immediately during 10 minuts.
Plasma is separated by centrifugation at º4C.
Plasma should be frozen within 1 hour and stored ad -20ºC until assayed.
Reference V.:
< 60.00 ng/L
Acromegaly > 300.00 ng/L
10077
GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY (G6PD GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
02/12/2010
10226
GP210 ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:65
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
29/09/2014
10230
GENE IL28B GENOTYPE (SNP rs12979860), BLOOD
Method:
Real Time PCR.
Mounting:
Delivery period:15
Sample:
3 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
09/09/2013
10251
GALACTOSE -1-PHOSPHATE, BLOOD
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:20
Sample:
2 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
< 0.60 umol/g Hb
10336
GHRELIN, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:35
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
1009.00 - 1461.00 pg/mL
10356
GQ-1b (TETRASIALOGANGLIOSIDES) ANTIBODIES, IgG, CFS
Method:
Immunoblot.
Mounting:
Delivery period:20
Sample:
2 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
10604
GLUTARIC ACIDURIA TYPE I (GCDH GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10733
GALACTOSEMIA CLASSIC (GALT GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10734
GALACTOSEMIA CLASSIC (GALT GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10735
GAUCHER DISEASE (GBA GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10736
GAUCHER DISEASE (GBA GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10745
GITELMAN SYNDROME (SLC12A3 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10746
GLYCOGEN STORAGE DISEASE TYPE Ia (G6PC GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10747
GLYCOGEN STORAGE DISEASE TYPE Ia (G6PC GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10748
GLYCOGEN STORAGE DISEASE TYPE Ib (SLC37A4 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10749
GLYCOGEN STORAGE DISEASE TYPE Ib (SLC37A4 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10750
GLUCOCORTICOID SUPPRESSIBLE ALDOSTERONISM (CYP11B1/CYP11B2 GENE), BLOOD
Method:
LD-PCR.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10966
GLUTARIC ACIDURIA TYPE I (GCDH GENE), AMNIOTIC FLUID
10996
GLANZMANN THROMBASTHENIA (ITGA2B GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11047
GLANZMANN THROMBASTHENIA (ITGB3 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11082
GLANZMANN THROMBASTHENIA (ITGA2B GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11161
GLANZMANN THROMBASTHENIA (ITGB3 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11757
GENOTYPE Rh (D), AMNIOTIC FLUID
Method:
Real Time PCR.
Mounting:
Delivery period:8
Sample:
5 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Reference V.:
Reported for each case
Review:
21/11/2013
11771
GLUCAGON, PLASMA 15 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:7
Sample:
500 uL Plasma 15 m. Tripotassium EDTA Trasylol (-8 ºC - Freeze)
Reference V.:
Not available
11772
GLUCAGON, PLASMA 30 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:7
Sample:
500 uL Plasma 30m Tripotassium EDTA Trasylol (-8 ºC - Freeze)
Reference V.:
Not available
11773
GLUCAGON, PLASMA 60 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:7
Sample:
500 uL Plasma 60m Tripotassium EDTA Trasylol (-8 ºC - Freeze)
Reference V.:
Not available
11774
GLUCAGON, PLASMA 90 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:7
Sample:
500 uL Plasma 90m Tripotassium EDTA Trasylol (-8 ºC - Freeze)
Reference V.:
Not available
11775
GLUCAGON, PLASMA 120 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:7
Sample:
500 uL Plasma 120m Tripotassium EDTA Trasylol (-8 ºC - Freeze)
Reference V.:
Not available
11776
GLUCAGON, PLASMA 180 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:7
Sample:
500 uL Plasma 180m Tripotassium EDTA Trasylol (-8 ºC - Freeze)
Reference V.:
Not available
11909
GLUTAMATE DEHYDROGENASE, CSF
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Not available
11928
GAMMA TOCOFEROL, SERUM
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:12
Sample:
1 mL Serum (-8 ºC - Freeze)
Reference V.:
1.19 - 7.19 umol/L * 0.41668 = mg/L
11997
GABA RECEPTOR B1 ANTIBODIES, CSF
Method:
Imunocitochemistry (Cell Based Assay) .
Mounting:
Delivery period:21
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
11/04/2015
14200
GIARDIA DNA, FECES
Method:
Real Time PCR.
Mounting:
Delivery period:12
Sample:
1 g Faeces (2-8 ºC - Refrigerate)
Reference V.:
Negative
14308
GELEOPHYSIC DYSPLASIA (ADAMTSL2 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
10/10/2014
14342
GALACTOSE-6-SULFPHATE SULPHATASE, LEUCOCYTES
Method:
Fluorimetry
Mounting:
Delivery period:32
Sample:
10 mL Total blood Heparin lithium (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
It´s necessary the birth date.
It´s necessary to contact previously with the laboratory for study programmation..
Reference V.:
50.00 - 253.00 nmol/17h/mg Prot.
14378
GABA RECEPTOR B1 ANTIBODIES, SERUM
Method:
Imunocitochemistry (Cell Based Assay) .
Mounting:
Delivery period:21
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
11/04/2015
14476
GASTRIN, SERUM 30 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Serum 30m (-8 ºC - Freeze)
Sample extraction:
Separate serum as soon as possible.
Patient preparation:
The patient should not drink coffee or tea while fasting.
The patient should not take antacids for 24 hours prior to the analysis.
The patient should not smoke during the 24 hours before the test.
Reference V.:
Review:
09/01/2015
14477
GASTRIN, SERUM 60 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Serum 60m (-8 ºC - Freeze)
Sample extraction:
Separate serum as soon as possible.
Patient preparation:
The patient should not drink coffee or tea while fasting.
The patient should not take antacids for 24 hours prior to the analysis.
The patient should not smoke during the 24 hours before the test.
Reference V.:
Review:
09/01/2015
14485
GOLD, SERUM
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:8
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
R.Values:
Minimun leval with oral administration: 300 ug/L
Reference V.:
< 0.51 µmol/l * 196.07 = µg/l
Therapeutical range bedore the next administration:
10.15 - 25.40 µmol/l * 196.07 = µg/l
2.54 - 25.40 µmol/l * 196.07 = µg/l
Review:
12/02/2015
14612
GIST (C-KIT GENE:: EXONS 9, 11, 13 and 17) TUMORAL TISSUE
Method:
PCR-Sequencing.
Mounting:
Delivery period:40
Sample:
1 piece/s Parafined tissue (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
28/01/2015
14625
GLIOMA (EXON 4 IDH1 GENE: SEQUENCING), TUMORAL TISSUE
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
1 piece/s Parafined tissue (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
21/02/2015
14626
GLIOMA (EXON 4 IDH2 GENE: SEQUENCING), TUMORAL TISSUE
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
1 piece/s Parafined tissue (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
21/02/2015
14642
GABA RECEPTOR A ANTIBODIES, CSF
Method:
Imunocitochemistry (Cell Based Assay) .
Mounting:
Delivery period:21
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
14643
GABA RECEPTOR A ANTIBODIES, SERUM
Method:
Imunocitochemistry (Cell Based Assay) .
Mounting:
Delivery period:21
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
14677
GAMMA INTERFERON, PLASMA
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:35
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Reference V.:
< 0.20 UI/mL
14787
GLUCOSE, ASCITIC FLUID
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Ascites fluid (2-8 ºC - Refrigerate)
Reference V.:
Not available
Review:
19/11/2015
14842
GRANULOMATOUS CHRONIC DISEASE (CYBA GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14843
GRANULOMATOUS CHRONIC DISEASE (CYBA GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14882
GASTRIN, SERUM Baseline
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Baseline serum (-8 ºC - Freeze)
Sample extraction:
Separate serum as soon as possible.
Patient preparation:
The patient should not drink coffee or tea while fasting.
The patient should not take antacids for 24 hours prior to the analysis.
The patient should not smoke during the 24 hours before the test.
Reference V.:
Both 1 16 Years 4.80 - 60.00 pmol/L * 2.08333 = ng/L
Both 0 4 Days 57.60 - 87.80 pmol/L * 2.08333 = ng/L
Both 17 60 Years < 51.84 pmol/L * 2.08333 = ng/L
14883
GASTRIN, SERUM 2 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample extraction:
Separate serum as soon as possible.
Patient preparation:
The patient should not drink coffee or tea while fasting.
The patient should not take antacids for 24 hours prior to the analysis.
The patient should not smoke during the 24 hours before the test.
Reference V.:

14884
GASTRIN, SERUM 5 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Serum 5 m (-8 ºC - Freeze)
Sample extraction:
Separate serum as soon as possible.
Patient preparation:
The patient should not drink coffee or tea while fasting.
The patient should not take antacids for 24 hours prior to the analysis.
The patient should not smoke during the 24 hours before the test.
Reference V.:

14885
GASTRIN, SERUM 10 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample extraction:
Separate serum as soon as possible.
Patient preparation:
The patient should not drink coffee or tea while fasting.
The patient should not take antacids for 24 hours prior to the analysis.
The patient should not smoke during the 24 hours before the test.
Reference V.:

14886
GASTRIN, SERUM 15 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Serum 15 m. (-8 ºC - Freeze)
Sample extraction:
Separate serum as soon as possible.
Patient preparation:
The patient should not drink coffee or tea while fasting.
The patient should not take antacids for 24 hours prior to the analysis.
The patient should not smoke during the 24 hours before the test.
Reference V.:

14887
GASTRIN, SERUM 20 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Serum 20 m. (-8 ºC - Freeze)
Sample extraction:
Separate serum as soon as possible.
Patient preparation:
The patient should not drink coffee or tea while fasting.
The patient should not take antacids for 24 hours prior to the analysis.
The patient should not smoke during the 24 hours before the test.
Reference V.:

14888
GASTRIN, SERUM 45 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Serum 45 m. (-8 ºC - Freeze)
Sample extraction:
Separate serum as soon as possible.
Patient preparation:
The patient should not drink coffee or tea while fasting.
The patient should not take antacids for 24 hours prior to the analysis.
The patient should not smoke during the 24 hours before the test.
Reference V.:

14889
GASTRIN, SERUM 90 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Serum 90m (-8 ºC - Freeze)
Sample extraction:
Separate serum as soon as possible.
Patient preparation:
The patient should not drink coffee or tea while fasting.
The patient should not take antacids for 24 hours prior to the analysis.
The patient should not smoke during the 24 hours before the test.
Reference V.:

14890
GASTRIN, SERUM 120 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Serum 120m (-8 ºC - Freeze)
Sample extraction:
Separate serum as soon as possible.
Patient preparation:
The patient should not drink coffee or tea while fasting.
The patient should not take antacids for 24 hours prior to the analysis.
The patient should not smoke during the 24 hours before the test.
Reference V.:

14945
GLUCOSAMINOGLUCANES TIPIFICATION, URINE
Method:
Two-dimensional electrophoresis.
Mounting:
Delivery period:32
Sample:
50 mL 24h urine (aliquot) (-8 ºC - Freeze)
Request form:
Clinical information required.
Reference V.:
Reported for each case
14946
GLUCOSE, PERICARDIC FLUID
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Pericardial fluid (2-8 ºC - Refrigerate)
Reference V.:
Not available
14951
GALACTOKNASE DEFICIENCY (GALK1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14953
GLUT1 DEFICIENCY SYNDROME 1 (SLC2A1 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14954
GLUT1 DEFICIENCY SYNDROME 1 (SLC2A1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14955
GLUT1 DEFICIENCY SYNDROME 1 (SLC2A1 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14971
GAD ANTIBODIES, CSF
Method:
Imunocitochemistry (Cell Based Assay) .
Mounting:
Delivery period:15
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
15010
GLUCAGON, PLASMA -30 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:7
Reference V.:
Not available
15097
GLYCOSYLATED FERRITIN, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:18
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
50.00 - 80.00 %
15328
GIRDLE MUSCULAR DYSTROPHY 2B (DYSF GENE: SEQ), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15338
GALACTOSE, PLASMA
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:18
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Perform bood extraction 3-4 hours after milk intake..
Reference V.:
< 300.00 nmol/mL
Adults < 120.00 nmol/mL
15356
GLYCOGEN STORAGE DISEASE VII (PFKM GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Place specimen on ice immediately.
Reference V.:
Reported for each case
15367
GENE TP53 SUPRESOR TUMORAL (MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15373
GLUTATHIONE REDUCED, BLOOD
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:21
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Both 16 30 Years 27.71 - 29.57 nmol/mg prot
Both 31 60 Years 24.96 - 27.44 nmol/mg prot
Both 1 15 Years 28.67 - 32.65 nmol/mg prot
Both 61 90 Years 19.60 - 20.98 nmol/mg prot
15420
GLUTATION OXIDIZED, BLOOD
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:21
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Both 16 30 Years 0.11 - 0.19 nmol/mg prot
Both 31 60 Years 0.11 - 0.23 nmol/mg prot
Both 61 90 Years 0.14 - 0.32 nmol/mg prot
Both 1 15 Years 0.08 - 0.12 nmol/mg prot
15569
GLYCINE ENCEPHALOPATHY (GLDC GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15570
GLYCINE ENCEPHALOPATHY (GLDC GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15571
GLYCINE ENCEPHALOPATHY (GLDC GENE: SEQUENCING), AMNIOTIC FLUID
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15572
GLYCINE ENCEPHALOPATHY (GLDC GENE: MLPA), AMNIOTIC FLUID
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15663
GLOMERULAR BASEMENT MEMBRANE ANTIBODIES, SERUM
Method:
Multiplex Fluorometric ImmunoAssay
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1.00 IA
Negative:
< 1.00 IA
15690
GLUTEN, FECES
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
2 g Faeces (-8 ºC - Freeze)
Reference V.:
Positive: >= to 0.16 ug GIP/g heces
Negative:
< 0.16 ug GIP/g heces
15722
GABAPENTIN, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
12.00 - 20.00 mg/L * 5.84 = µmol/L
15846
GALACTOCEREBROSIDASE, LEUCOCYTES
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:30
Sample:
10 mL Total blood Heparin lithium (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
It´s necessary the birth date.
It´s necessary to contact previously with the laboratory for study programmation..
Reference V.:
10.00 - 78.00 nmol/17h/mg prt
15847
GENE TP53 SUPRESOR TUMORAL (KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
16104
GENTAMICIN, SERUM
Method:
Enzyme multiplied immunoassay technique.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Therapeutic R.:

Peak 10.40 - 20.90 umol/L * 0.478469 = ug/mL
Trough < 8.36 umol/L * 0.478469 = ug/mL
Toxic C.:

Peak >= to 20.90 umol/L * 0.478469 = ug/mL
Trough >= to 8.36 umol/L * 0.478469 = ug/mL